Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
biological_reference_interval [2025/01/30 06:36] – adminbiological_reference_interval [2025/01/30 06:49] (current) – admin
Line 16: Line 16:
 | | |1 week -18 years|0-2.0|mg/dL| | | |  | | |1 week -18 years|0-2.0|mg/dL| | | |
 | | |Adult|0.2-1.5|mg/dL| | | |  | | |Adult|0.2-1.5|mg/dL| | | |
-6 Bilirubin Direct Child & Adult 0.0-0.5 mg/dL Diazo Reaction 0.04mg/Dl 0.1 to 15mg/dL +|6|Bilirubin Direct Child & Adult 0.0-0.5 mg/dL Diazo Reaction 0.04mg/Dl 0.1 to 15mg/dL 
-7 Alanine aminotransferase male <45 U/L NADH (without P-5’-P) 2U/L 942 U/L +|7|Alanine aminotransferase male <45 U/L NADH (without P-5’-P) 2U/L 942 U/L 
- Female <34 U/L  +| | |Female <34 U/L  
-8 Aspartate aminotransferase male <35 U/L NADH (without P-5'-P) 2U/L 913U/L +|8| Aspartate aminotransferase male <35 U/L NADH (without P-5'-P) 2U/L 913U/L 
- Female <31 U/L  +| | |Female <31 U/L  
-9 AlkalinePhosphatase 0-15 y 54-369 U/L Para-nitrophenyl Phosphate 1.6 U/L 1200 U/L +|9| AlkalinePhosphatase 0-15 y 54-369 U/L Para-nitrophenyl Phosphate 1.6 U/L 1200 U/L 
- 16-50 y 53-128 U/L  +| | |16-50 y|53-128|U/L| | | |  
- >50 y Male 56-119 U/L  +| | |>50 y| Male|56-119|U/L| | | |  
- >50 y Female 53-141 U/L +| | |>50 y| Female|53-141|U/L| | | |
 10 Protein, total 0-7 days 4.4-7.6 g/dL Biuret 0.5 g/dl 18.4 g/dl 10 Protein, total 0-7 days 4.4-7.6 g/dL Biuret 0.5 g/dl 18.4 g/dl
- <1 y 5.1-7.3 g/dL  +| | |<1 y|5.1-7.3|g/dL| | | |  
- 1-2 y 5.6-7.5 g/dL  +| | |1-2 y|5.6-7.5|g/dL|| | |  
- >2 y 6.0-8.0 g/dL  +| | |>2 y|6.0-8.0|g/dL| | | |  
-11 Albumin Child & Adult 3.5-5.0 g/dL Colorimetric (Bromocresol Green) 0.3 g/dl 10.5 g/dl +|11| Albumin Child & Adult 3.5-5.0 g/dL Colorimetric (Bromocresol Green) 0.3 g/dl 10.5 g/dl 
-12 GLOBULIN Child & Adult 2.9-3.1 g/dL  +|12| GLOBULIN Child & Adult 2.9-3.1 g/dL | | |  
-13 A:G ratio Child & Adult 1.2-1.5 : 1  +|13| A:G ratio Child & Adult 1.2-1.5 : 1  
-14 Uric acid Male 3.5-7.2 mg/dL Uricase 0.06 mg/dl 33.1 mg/dl +|14| Uric acid Male 3.5-7.2 mg/dL Uricase 0.06 mg/dl 33.1 mg/dl| | | 
- Female 2.6-6.0 mg/dL  +| | | Female 2.6-6.0 mg/dL  
-15 "Lactate dehydrogenase (LD) +|15| "Lactate dehydrogenase (LD) 
- Total L →P" 0-12 y 180-360 U/L Kinetic- Lactate to Pyruvate. 14 U/L 2000U/L +| | | Total L →P" 0-12 y 180-360 U/L Kinetic- Lactate to Pyruvate. 14 U/L 2000U/L 
- 12-60 y 125-220 U/L  +| | | 12-60 y 125-220 U/L  
-16 Amylase Adult 28-100 U/L CNPG3 Enzymatic/Colorimetric  +|16| Amylase Adult 28-100 U/L CNPG3 Enzymatic/Colorimetric  
-17 Lipase Adult <38 U/L Quinone dye 1.6 U/L 1200 U/L +|17| Lipase Adult <38 U/L Quinone dye 1.6 U/L 1200 U/L 
-18 Cholinesterase Male 40-78 U/L  +|18| Cholinesterase Male 40-78 U/L  
- Female 33-76 U/L  +| | | Female 33-76 U/L  
-19 Iron 0-13 years 16-128 µg/dL Ferene- Endpoint  +|19| Iron 0-13 years 16-128| µg/dL Ferene- Endpoint  
- 14-18 years (female) 20-162 µg/dL  +| | |14-18 years (female)| 20-162| µg/dL | | |  
- 14-18 years (male) 31-168 µg/dL  +| | |14-18 years (male)| 31-168| µg/dL | | |  
- Adult Female 50-170 µg/dL  +| | |Adult Female| 50-170 µg/dL | | |  
- Adult Male 65-175 µg/dL  +| | |Adult Male 65-175 µg/dL | | |  
-20 UIBC Male 69-240 µg/dL Ferene  +|20| UIBC |Male| 69-240| µg/dL| Ferene | | |  
- Female 70-310 µg/dL  +| | |Female |70-310| µg/dL| | | |  
-21 TIBC Male  +|21|TIBC|Male | | | |  
- Female  +| | |Female | | | |  
-22 Ferritin 1 mo 200-600 ng/mL CMIA  +|22|Ferritin|1 mo|200-600|ng/mL|CMIA| | |  
- 0-1 Y 50-200 ng/mL  +| | |0-1 Y|50-200|ng/mL| | | |  
- 1-15 y 7-140 ng/mL  +| | |1-15 y|7-140|ng/mL| | |  
- Male 20-250 ng/mL  +| | |Male|20-250|ng/mL| | | |  
- Female 10-120 ng/mL  +| | |Female|10-120|ng/mL| | | |  
-23 Calcium, total Child and adult 8.6-10.2 mg/dL Arsenazo III  +|23|Calcium, total|Child and adult|8.6-10.2|mg/dL| Arsenazo III| | |  
-24 Magnesium 0-6 y 1.7-2.3 mg/dL Enzymatic-Isocitrate dehydrogenase  +|24|Magnesium|0-6 y|1.7-2.3|mg/d|Enzymatic-Isocitrate dehydrogenase| | |  
- 7-12 y 1.7-2.1 mg/dL  +| | |7-12 y|1.7-2.1|mg/dL| | | | 
- >12 y 1.6-2.6 mg/dL  +| | |>12 y|1.6-2.6|mg/dL| | | |  
-25 Sodium (Na) Child 138-145 mEq/L ISE-Direct  +|25| Sodium (Na) Child 138-145 mEq/L ISE-Direct  
- Adult 136-145 mEq/L  +| | | Adult 136-145 mEq/L | | |  
-26 Potassium Infant 4.1-5.3 mEq/L ISE-Direct  +|26| Potassium Infant 4.1-5.3 mEq/L ISE-Direct  
- Child 3.4-4.7 mEq/L  +| | | Child 3.4-4.7 mEq/L | | |  
- Adults 3.5-5.1 mEq/L  +| | | Adults 3.5-5.1 mEq/L | | |  
- Newborn 3.7-5.9 mEq/L  +| | | Newborn 3.7-5.9 mEq/L | | |  
-27 Chloride (Cl) Adult 98-107 mEq/L ISE-Direct  +|27| Chloride (Cl) Adult 98-107 mEq/L ISE-Direct  
-28 Triiodothyronine (T3), free Child and adult 2.10-4.40 pg/mL CMIA 1.10pg/ml29.91pg/ml  +|28| Triiodothyronine (T3), free Child and adult 2.10-4.40 pg/mL CMIA 1.10pg/ml29.91pg/ml  
-29 Thyroxine, free (FT4) 1-4 d 2.2-5.3 ng/dL CMIA 0.28 ng/dl 5ng/dl +|29| Thyroxine, free (FT4) 1-4 d 2.2-5.3 ng/dL CMIA 0.28 ng/dl 5ng/dl 
- 2 wk-20 y 0.8-2.0 ng/dL  +| | | 2 wk-20 y 0.8-2.0 ng/dL | | |  
- 21-87 y 0.8-2.7 ng/dL  +| | | 21-87 y 0.8-2.7 ng/dL | | |  
-30 Thyrotropin (thyroid-stimulating hormone) (TSH) Birth-4 d 1.0-39.0 µIU/mL CMIA 0.0109µIU/L 127.98169µIU/L +|30| Thyrotropin (thyroid-stimulating hormone) (TSH) Birth-4 d 1.0-39.0 µIU/mL CMIA 0.0109µIU/L 127.98169µIU/L 
- 2-20 wk 1.7-9.1 µIU/mL  +| | | 2-20 wk 1.7-9.1 µIU/mL | | |  
- 21 wk-20 y 0.7-6.4 µIU/mL  +| | | 21 wk-20 y 0.7-6.4 µIU/mL | | |  
- 21-54 y 0.4-4.2 µIU/mL  +| | | 21-54 y 0.4-4.2 µIU/mL | | |  
- 55-87 y 0.5-8.9 µIU/mL  +| | | 55-87 y 0.5-8.9 µIU/mL | | |  
-31 Triiodothyronine (T3), total 1-3 d 100-740 ng/dL CMIA 0.25ng/ml 5.83ng/ml +|31| Triiodothyronine (T3), total 1-3 d 100-740 ng/dL CMIA 0.25ng/ml 5.83ng/ml 
- 1-11 mo 105-245 ng/dL  +| | | 1-11 mo 105-245 ng/dL | | |  
- 1-5 y 105-269 ng/dL  +| | | 1-5 y 105-269 ng/dL | | |  
- 6-10 y 94-241 ng/dL  +| | | 6-10 y 94-241 ng/dL | | |  
- 11-15 y 82-213 ng/dL  +| | | 11-15 y 82-213 ng/dL | | |  
- 16-20 y 80-210 ng/dL  +| | | 16-20 y 80-210 ng/dL | | |  
- 20-50 y 70-204 ng/dL  +| | | 20-50 y 70-204 ng/dL | | |  
- 50-90 y 40-181 ng/dL  +| | | 50-90 y 40-181 ng/dL | | |  
-32 Thyroxine (T4) 1-3 d 11.8-22.6 µg/dL CMIA 1.03ug/dl 20.55ug/dl +|32| Thyroxine (T4) 1-3 d 11.8-22.6 µg/dL CMIA 1.03ug/dl 20.55ug/dl 
- 1-2 wk 9.9-16.6 µg/dL  +| | | 1-2 wk 9.9-16.6 µg/dL | | |  
- 1-4 mo 7.2-14.4 µg/dL  +| | | 1-4 mo 7.2-14.4 µg/dL | | |  
- 4-12 mo 7.8-16. µg/dL  +| | | 4-12 mo 7.8-16. µg/dL | | |  
- 1-15 y 5.6-11.7 µg/dL  +| | | 1-15 y 5.6-11.7 µg/dL | | |  
-  Adult  Males 4.6-10.5 µg/dL  +| | |  Adult  Males 4.6-10.5 µg/dL | | |  
-  Adult  Females 5.5-11.0 µg/dL  +| | |  Adult  Females 5.5-11.0 µg/dL | | |  
-33 U, 24 h Adult <100 mg/day  +|33| U, 24 h Adult <100 mg/day | | | 
-34 CSF Full-term newborn 40-120 mg/dL Turbidimetric- Benzethonium Chloride  +|34| CSF Full-term newborn 40-120 mg/dL Turbidimetric- Benzethonium Chloride  
- < 1 mo 20-80 mg/dL  +| | | < 1 mo 20-80 mg/dL | | |  
- >1 mo 15-40 mg/dL  +| | | >1 mo 15-40 mg/dL | | |  
-35 CSF Infant, child 60-80 mg/dL  +|35| CSF Infant, child 60-80 mg/dL | | |  
- Adult 40-70 mg/dL  +| | | Adult 40-70 mg/dL | | |  
-36 CKMB 0-25 U/L IFCC Method/Immunoinhibition 3 U/L 1000U/L +|36| CKMB 0-25 U/L IFCC Method/Immunoinhibition 3 U/L 1000U/L 
-37 Troponin I 0-75 pg/mL  +|37| Troponin I 0-75 pg/mL | | |  
-  +| | | | | |  
-38 Vitamin B12 206-678 pg/mL CMIA 125pg/ml 2769pg/ml +|38| Vitamin B12 206-678 pg/mL CMIA 125pg/ml 2769pg/ml 
- Acceptable (WHO) >201 pg/mL  +| | | Acceptable (WHO) >201 pg/mL  
- Deficiency (WHO) <150 pg/mL  +| | | Deficiency (WHO) <150 pg/mL  
-  +  
-39 PCO2 Infant 27-41 mm Hg  +|39| PCO2 Infant 27-41 mm Hg | | |  
- Adult M 35-48 mm Hg  +| | | Adult M 35-48 mm Hg | | |  
- Adult F 32-45 mm Hg  +| | | Adult F 32-45 mm Hg | | | 
-40 Oxygen, partial pressure (PO2) 1 d 54-95 mm Hg  +|40| Oxygen, partial pressure (PO2) 1 d 54-95 mm Hg  
- 2 d-60 y 83-108 mm Hg  +| | | 2 d-60 y 83-108 mm Hg  
-41 pH 7.35-7.45  +|41| pH 7.35-7.45  
-42 Procalcitonin  +|42| Procalcitonin  
-43 Interleukin 6 +|43| Interleukin 6
  PSA   PSA